Search research articles
Contact Us
Filters
Showing results (81-90 of 97) with videos related to
Page
of 10
Sort By:
Pathogens & Immunity
|
May 20, 2026
Impact of Sex on Viral Shedding and Symptom Severity During Acute COVID-19
Evelyn Kung, Rinki Deo, Manish C Choudhary, et al.
Cell Reports. Medicine
|
July 6, 2022
Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection
Julie Boucau, Kara W Chew, Manish C Choudhary, et al.
Journal of Viral Hepatitis
|
March 12, 2022
Determining the lower limit of detection required for HCV viral load assay for test of cure following direct-acting antiviral-based treatment regimens: Evidence from a global data set
Jake R Morgan, Elizabeth Marsh, Alexandra Savinkina, et al.
JAMA Network Open
|
April 26, 2023
Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19: 2 Randomized Clinical Trials
Rachel A Bender Ignacio, Kara W Chew, Carlee Moser, et al.
The Journal of Infectious Diseases
|
February 17, 2026
Impact of COVID-19 Monoclonal Antibody Therapy on Subsequent Vaccine-elicited SARS-CoV-2 Immune Responses
Davey Smith, Isabelle R Weir, Sydney Ramirez, et al.
Open Forum Infectious Diseases
|
September 22, 2025
Rapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody Therapy
Rinki Deo, Manish C Choudhary, Owen T Glover, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 29, 2024
2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Management of COVID-19: Anti-SARS-CoV-2 Neutralizing Antibody Pemivibart for Pre-exposure Prophylaxis
Adarsh Bhimraj, Yngve Falck-Ytter, Arthur Y Kim, et al.
Annals of Internal Medicine
|
April 17, 2023
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19
Teresa H Evering, Kara W Chew, Mark J Giganti, et al.
Nature Microbiology
|
October 27, 2022
Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial
Manish C Choudhary, Kara W Chew, Rinki Deo, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 21, 2021
Emergence of SARS-CoV-2 Resistance with Monoclonal Antibody Therapy
Manish C Choudhary, Kara W Chew, Rinki Deo, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 97) with videos related to
Sort By:
Page
of 10
Pathogens & Immunity
|
May 20, 2026
Impact of Sex on Viral Shedding and Symptom Severity During Acute COVID-19
Evelyn Kung, Rinki Deo, Manish C Choudhary, et al.
Cell Reports. Medicine
|
July 6, 2022
Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection
Julie Boucau, Kara W Chew, Manish C Choudhary, et al.
Journal of Viral Hepatitis
|
March 12, 2022
Determining the lower limit of detection required for HCV viral load assay for test of cure following direct-acting antiviral-based treatment regimens: Evidence from a global data set
Jake R Morgan, Elizabeth Marsh, Alexandra Savinkina, et al.
JAMA Network Open
|
April 26, 2023
Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19: 2 Randomized Clinical Trials
Rachel A Bender Ignacio, Kara W Chew, Carlee Moser, et al.
The Journal of Infectious Diseases
|
February 17, 2026
Impact of COVID-19 Monoclonal Antibody Therapy on Subsequent Vaccine-elicited SARS-CoV-2 Immune Responses
Davey Smith, Isabelle R Weir, Sydney Ramirez, et al.
Open Forum Infectious Diseases
|
September 22, 2025
Rapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody Therapy
Rinki Deo, Manish C Choudhary, Owen T Glover, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 29, 2024
2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Management of COVID-19: Anti-SARS-CoV-2 Neutralizing Antibody Pemivibart for Pre-exposure Prophylaxis
Adarsh Bhimraj, Yngve Falck-Ytter, Arthur Y Kim, et al.
Annals of Internal Medicine
|
April 17, 2023
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19
Teresa H Evering, Kara W Chew, Mark J Giganti, et al.
Nature Microbiology
|
October 27, 2022
Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial
Manish C Choudhary, Kara W Chew, Rinki Deo, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 21, 2021
Emergence of SARS-CoV-2 Resistance with Monoclonal Antibody Therapy
Manish C Choudhary, Kara W Chew, Rinki Deo, et al.
Page
of 10